Kim Giffoni serves as Executive at Targeted Medical Pharma, Inc., where they oversee executive responsibilities. Since joining the company, Kim Giffoni has executed 12 insider transactions totaling $20.7K, demonstrating a bullish approach to their equity position. Their most recent transaction on Mar 4, 2016 involved receiving (via award) 547,500 shares valued at $27.4K.
Kim Giffoni currently holds 751,095 shares of Targeted Medical Pharma, Inc. (TRGM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kim Giffoni has been a net buyer of TRGM stock. They have purchased $20.7K and sold $0 worth of shares.
Kim Giffoni's most recent insider trade was on Mar 4, 2016, when they sold 547,500 shares at $0.05 per share.
Get notified when new Form 4 filings are submitted
| $0.20 |
| Discretionary |
| May 20, 2015 | TRGM | $13.6K | Award | 68,077 | $0.20 | Discretionary |
| Apr 9, 2014 | TRGM | $3.4K | Purchase | 4,000 | $0.84 | Discretionary |
| Apr 9, 2014 | TRGM | $830 | Purchase | 1,000 | $0.83 | Discretionary |
| Dec 12, 2013 | TRGM | $900 | Purchase | 1,000 | $0.90 | Discretionary |
| Dec 11, 2013 | TRGM | $880 | Purchase | 1,000 | $0.88 | Discretionary |
| Dec 10, 2013 | TRGM | $6.7K | Purchase | 7,480 | $0.90 | Discretionary |
| Dec 9, 2013 | TRGM | $2.9K | Purchase | 3,500 | $0.83 | Discretionary |
| Dec 2, 2013 | TRGM | $1.8K | Purchase | 1,700 | $1.05 | Discretionary |
| Nov 29, 2013 | TRGM | $654 | Purchase | 600 | $1.09 | Discretionary |
| Nov 27, 2013 | TRGM | $2.6K | Purchase | 2,500 | $1.06 | Discretionary |